Biomea Fusion BMEA
NASDAQ BMEA
$0.69 -0.05 (-6.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Return on Sales [ROS] (2024 - 2026)

Updated

Analysis

Biomea Fusion (BMEA) Return on Sales [ROS] (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Biomea Fusion 50.53 Mn -131.81 Mn - -4,001.88%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,001.88%
Mar 31, 2026 -2,970.70%
Dec 31, 2025 -5,120.29%
Sep 30, 2025 -473.06%
Jun 30, 2025 -6,885.44%
Mar 31, 2025 -6,602.67%
Dec 31, 2024 -3,895.60%
Sep 30, 2024 -2,718.77%
Jun 30, 2024 -2,398.15%
Mar 31, 2024 -2,055.01%
API Access

Biomea Fusion Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMEA&period=max&api_key=YOUR_API_KEY